STAT+: Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
Roche is reviewing all future investments in Germany over health care cost-cutting policies, with a top executive citing a loss of trust
Roche is reviewing all future investments in Germany over health care cost-cutting policies, with a top executive citing a loss of trust
comments(0)
5-min edit window · permanent after that